142 related articles for article (PubMed ID: 33848528)
1. Intra-Articular Dual Drug Delivery for Synergistic Rheumatoid Arthritis Treatment.
Zewail M; Nafee N; Boraie N
J Pharm Sci; 2021 Jul; 110(7):2808-2822. PubMed ID: 33848528
[TBL] [Abstract][Full Text] [Related]
2. Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers.
Zewail M; Nafee N; Helmy MW; Boraie N
Drug Deliv Transl Res; 2021 Dec; 11(6):2496-2519. PubMed ID: 34013458
[TBL] [Abstract][Full Text] [Related]
3. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
Zewail M; Nafee N; Helmy MW; Boraie N
Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
[TBL] [Abstract][Full Text] [Related]
4. Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Zewail MB; El-Gizawy SA; Asaad GF; Shabana ME; El-Dakroury WA
Int J Pharm; 2023 Aug; 643():123224. PubMed ID: 37451327
[TBL] [Abstract][Full Text] [Related]
5. Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.
Reum Son A; Kim DY; Hun Park S; Yong Jang J; Kim K; Ju Kim B; Yun Yin X; Ho Kim J; Hyun Min B; Keun Han D; Suk Kim M
Sci Rep; 2015 Oct; 5():14713. PubMed ID: 26424611
[TBL] [Abstract][Full Text] [Related]
6. Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis.
Siddiqui B; Ur Rehman A; Gul R; Chaudhery I; Shah KU; Ahmed N
Carbohydr Polym; 2024 Mar; 327():121683. PubMed ID: 38171692
[TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of Novel Leflunomide SPION Bioemulsomes for the Intra-Articular Treatment of Arthritis.
Abbas H; Gad HA; El Sayed NS; Rashed LA; Khattab MA; Noor AO; Zewail M
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297441
[TBL] [Abstract][Full Text] [Related]
8. Folic acid decorated chitosan-coated solid lipid nanoparticles for the oral treatment of rheumatoid arthritis.
Zewail M
Ther Deliv; 2021 Apr; 12(4):297-310. PubMed ID: 33726498
[No Abstract] [Full Text] [Related]
9. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
10. Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy.
Zhao YP; Han JF; Zhang FY; Liao TT; Na R; Yuan XF; He GB; Ye W
Drug Deliv; 2022 Dec; 29(1):2269-2282. PubMed ID: 35815790
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers.
Chapa-Villarreal FA; Stephens M; Pavlicin R; Beussman M; Peppas NA
Adv Drug Deliv Rev; 2024 May; 208():115300. PubMed ID: 38548104
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system.
Akrami-Hasan-Kohal M; Eskandari M; Solouk A
Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443
[TBL] [Abstract][Full Text] [Related]
13. Changes in focal adhesion kinase expression in rats with collagen-induced arthritis and efficacy of intervention with disease modifying anti-rheumatic drugs alone or in combination.
Gao HY; Luo J; Li XF; Lv Q; Wen HY; Song QZ; Zhao WP; Zhao XC; Zhang TT; Zhang SY; Zhi JM
Int J Clin Exp Pathol; 2015; 8(12):15573-81. PubMed ID: 26884826
[TBL] [Abstract][Full Text] [Related]
14. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.
Wang D; Miller SC; Liu XM; Anderson B; Wang XS; Goldring SR
Arthritis Res Ther; 2007; 9(1):R2. PubMed ID: 17233911
[TBL] [Abstract][Full Text] [Related]
15. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Ni R; Song G; Fu X; Song R; Li L; Pu W; Gao J; Hu J; Liu Q; He F; Zhang D; Huang G
Biomaterials; 2020 Feb; 232():119730. PubMed ID: 31918224
[TBL] [Abstract][Full Text] [Related]
17. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.
Chiesa E; Pisani S; Colzani B; Dorati R; Conti B; Modena T; Braekmans K; Genta I
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30082640
[TBL] [Abstract][Full Text] [Related]
18. A novel indomethacin/methotrexate/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis.
Yin N; Tan X; Liu H; He F; Ding N; Gou J; Yin T; He H; Zhang Y; Tang X
Nanoscale; 2020 Apr; 12(15):8546-8562. PubMed ID: 32243486
[TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.
Hajialilo M; Ghorbanihaghjo A; Valaee L; Kolahi S; Rashtchizadeh N; Amirkhiz MB; Malekmahdavi I; Khabbazi A
Clin Rheumatol; 2016 Dec; 35(12):2887-2891. PubMed ID: 27572327
[TBL] [Abstract][Full Text] [Related]
20. Development and in vivo evaluation of therapeutic phytosomes for alleviation of rheumatoid arthritis.
Nashaat D; Elsabahy M; Hassanein KMA; El-Gindy GA; Ibrahim EH
Int J Pharm; 2023 Sep; 644():123332. PubMed ID: 37625602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
